About Bairitone Health
Bairitone Health is building the missing link in sleep apnea care: a wearable diagnostic patch that finally connects the what and the why. Today, millions of people are diagnosed with obstructive sleep apnea (OSA), but treatment success is low because the underlying cause of obstruction is unknown. Bairitone’s passive acoustic sensing maps the airway during natural sleep to reveal whether collapse occurs at the tongue, palate, or epiglottis, enabling doctors to match patients to the right treatment on day one. This approach moves the gold-standard diagnostic (DISE) out of the operating room and into the home, transforming a costly, invasive procedure into a scalable, comfortable, and predictive test. The company’s breakthrough approach is already clinically validated and has attracted FDA support for the Breakthrough Device Pathway.
Themes & SDGs Supported
Mission and Vision
Bairitone Health is redefining how sleep apnea is detected and managed through accessible, data-driven technology that brings diagnosis and care into everyday life. Our mission is to improve health equity and outcomes by making high-quality sleep health available to everyone, everywhere.
Investment Terms
To view Terms/Materials, you must have a CataCap account and be logged in. Access to full materials is available to Donor/Investors with an active CataCap balance.
If you do not have an active balance, you may contact the company or fund directly using the “Questions about this investment?” link, or email [email protected] for assistance.
Investment Materials
To view Materials/Terms, you must have a CataCap account and be logged in. Access to full materials is available to Donor/Investors with an active CataCap balance.
If you do not have an active balance, you may contact the company or fund directly using the “Questions about this investment?” link, or email [email protected] for assistance.